Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yap

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Oncogene|December 20, 2017
Dual role of autophagy in hallmarks of cancerShikha Satendra Singh, Somya Vats, Amelia Yi-Qian Chia, et al.
Theranostics|January 4, 2021
Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2019
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II StudyMargaret von Mehren, Suzanne George, Michael C Heinrich, et al.
Biological Reviews of the Cambridge Philosophical Society|January 30, 2015
microRNAs in breast cancer: regulatory roles governing the hallmarks of cancerJen N Goh, Ser Y Loo, Arpita Datta, et al.
Diabetologia|February 8, 2011
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesJ M Forbes, J Söderlund, F Y T Yap, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapyE Ben-Ami, C M Barysauskas, M von Mehren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomasSuzanne George, Priscilla Merriam, Robert G Maki, et al.
Journal of the National Cancer Institute|January 27, 2017
Wanted DEAD/H or Alive: Helicases Winding Up in CancersWanpei Cai, Zhi Xiong Chen, Grishma Rane, et al.
British Journal of Pharmacology|July 25, 2017
'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signallingMei S Ong, Wanpei Cai, Yi Yuan, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 13, 2016
Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancerChen Xie, Vinod Vijay Subhash, Arpita Datta, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Oncogene|December 20, 2017
Dual role of autophagy in hallmarks of cancerShikha Satendra Singh, Somya Vats, Amelia Yi-Qian Chia, et al.
Theranostics|January 4, 2021
Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2019
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II StudyMargaret von Mehren, Suzanne George, Michael C Heinrich, et al.
Biological Reviews of the Cambridge Philosophical Society|January 30, 2015
microRNAs in breast cancer: regulatory roles governing the hallmarks of cancerJen N Goh, Ser Y Loo, Arpita Datta, et al.
Diabetologia|February 8, 2011
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesJ M Forbes, J Söderlund, F Y T Yap, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2016
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapyE Ben-Ami, C M Barysauskas, M von Mehren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomasSuzanne George, Priscilla Merriam, Robert G Maki, et al.
Journal of the National Cancer Institute|January 27, 2017
Wanted DEAD/H or Alive: Helicases Winding Up in CancersWanpei Cai, Zhi Xiong Chen, Grishma Rane, et al.
British Journal of Pharmacology|July 25, 2017
'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signallingMei S Ong, Wanpei Cai, Yi Yuan, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 13, 2016
Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancerChen Xie, Vinod Vijay Subhash, Arpita Datta, et al.
Pageof 15